Showing results (21-30 of 252) with videos related to

Sort By:
Pageof 26
Oncoimmunology|July 4, 2012
Association of a functional Indoleamine 2,3-dioxygenase 2 genotype with specific immune responsesTania Køllgaard, Tobias Wirenfeldt Klausen, Manja Idorn, et al.
Plos One|July 16, 2015
Pre-Vaccination Frequencies of Th17 Cells Correlate with Vaccine-Induced T-Cell Responses to Survivin-Derived Peptide EpitopesTania Køllgaard, Selma Ugurel-Becker, Manja Idorn, et al.
International Journal of Cancer|January 9, 2004
HLA-B35-restricted immune responses against survivin in cancer patientsSine Reker, Jürgen C Becker, Inge Marie Svane, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2008
The immunogenicity of the hTERT540-548 peptide in cancerLynn Wenandy, Rikke Baek Sørensen, Lisa Sengeløv, et al.
Cancer Immunology, Immunotherapy : CII|July 20, 2006
Efficient tumor cell lysis mediated by a Bcl-X(L) specific T cell clone isolated from a breast cancer patientRikke Baek Sørensen, Sine Reker Hadrup, Tania Køllgaard, et al.
Cancer Biology & Therapy|April 4, 2006
Persistence of survivin specific T cells for seven years in a melanoma patient during complete remissionSine Reker Hadrup, Julie Gehl, Rikke Baek Sørensen, et al.
Cancer Immunology, Immunotherapy : CII|February 21, 2008
Cancer treatment: the combination of vaccination with other therapiesMads Hald Andersen, Rikke Baek Sørensen, David Schrama, et al.
Blood|November 17, 2010
Indoleamine 2,3-dioxygenase specific, cytotoxic T cells as immune regulatorsRikke Baek Sørensen, Sine Reker Hadrup, Inge Marie Svane, et al.
Seminars in Cancer Biology|March 6, 2004
Dynamic changes of specific T cell responses to melanoma correlate with IL-2 administrationMads Hald Andersen, Julie Gehl, Sine Reker, et al.
The Journal of Clinical Investigation|August 8, 2009
Identification of heme oxygenase-1-specific regulatory CD8+ T cells in cancer patientsMads Hald Andersen, Rikke Baek Sørensen, Marie K Brimnes, et al.
Pageof 26